New dedicated thrombosis service launched for cancer patients at University Hospitals of North Midlands
Cancer patients from Stoke-on-Trent and Staffordshire can now benefit from a dedicated service launched at University Hospitals of North Midlands.
Approximately 20 per cent of cancer patients face an increased risk of Venous Thromboembolism (VTE) and major bleeding and the new service at Royal Stoke University Hospital will help thousands of local people receive treatment quickly when they need it.
Developed in partnership with Staffordshire Thrombosis Anticoagulation Service (STAC) and UHNM’s oncology team, the Cancer Associated Thrombosis (CAT) service provides specialist input to oncologists, clinicians, surgeons and general practitioners. This improves overall patient care and means that patients can access the treatment they need quickly.
Dr Shahid Gilani, Specialist doctor in Clinical Oncology said: “Cancer is the highest single risk factor for thrombosis therefore the CAT Clinic will play an important role in improving both the outcomes and quality of life in these patients. We now have a dedicated team to manage cancer patients with thrombosis and in need of anticoagulation ensuring that patients get assessed, diagnosed and treated quickly. We are also able to provide patient education and support, something vital as part of the recovery process.”
Photo - L-R Dr Chandra Deepak, Dr Rajanee Bhana and Dr Shahid Gilani